drugset / Trial / NCT01836861
IPI-145 ADME and Absolute Bioavailability Study
NaSingle-groupOpen-labelBasic science
Summary
This is an open-label, 2-period, absorption, distribution, metabolism and excretion (ADME) and absolute bioavailability study in 6 healthy adult male subjects.
Timeline
- Start
- 2013-03
- Primary completion
- 2013-04
- Completion
- 2013-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Duvelisib | Small molecule | 2.8 ug | Intravenous |
| Subject | Duvelisib | Small molecule | 25 mg | Intravenous |
Indications
No indication recorded.